November 9, 2026
Nordic Rebalance takes ReFerm®, its Swedish-proven postbiotic platform, to Germany
More than 14,000 consumers in Sweden have already used ReFerm® – now the clinically studied, gut-barrier branded ingredient is going international for the first time, as German healthcare company vitOrgan launches NeyBiotics®, Powered by ReFerm®, on 1 October.

1st of October, German healthcare company vitOrgan Arzneimittel GmbH launches NeyBiotics®, Powered by ReFerm® – the first international commercial launch built on Nordic Rebalance's clinically studied postbiotic ingredient. It marks the Swedish company's entry into Germany, one of Europe's largest healthcare markets, and represents a decisive step: from taking more than 20 years of research all the way to Swedish consumers, to enabling established healthcare and nutrition companies to build differentiated products and new growth opportunities on the ReFerm® platform.
ReFerm® is a new generation of gut-health solutions, made using Nordic Rebalance's proprietary, patent-pending production technology. Nordic oats are fermented with Lactobacillus plantarum DSM 9843 to create a complex, food-based bioactive matrix – rich in metabolites that support the gut barrier and the metabolism of the residing microbiota.
What sets Nordic Rebalance apart is that it has already taken this science all the way to consumers itself.
“Unusually for a postbiotics company, we didn't stop at research – we took ReFerm® all the way to more than 14,000 consumers ourselves before we ever offered it to a partner. That gives our partners something rare: not just science, but evidence of real consumer relevance. It's exactly what convinced vitOrgan, a 70-year-old, family-owned pharmaceutical company, to build on it,” says Caroline Lilja Olsson, CEO of Nordic Rebalance.
“What also excites us about ReFerm® is that it takes a genuinely different approach to something that affects people everywhere – gut health is one of the biggest, most universal health topics there is, yet the category has looked much the same for years. We've selected it as a scientific and product-development platform with real potential to support our future innovation and growth. For us, this is a strategic launch, not simply a new product,” says Jürgen Leist, Managing Director of vitOrgan Arzneimittel GmbH.
Nordic Rebalance is opening conversations with commercial and product-development leaders at supplement, functional-nutrition and wellness brands who want to explore what a similar partnership could look like.
Contact
Caroline Lilja Olsson
CEO
Nordic Rebalance
caroline.lilja-olsson@nordicrebalance.com
+46 (0) 70 205 93 11
Contact
About Nordic Rebalance
Nordic Rebalance AB is an innovative, science-led nutrition company based in Malmö, developing postbiotic solutions from Nordic oats using our proprietary, patent-pending production technology. ReFerm®, our branded ingredient, is a new generation of postbiotics built around the gut barrier: clinically studied and used by more than 14,000 Swedish consumers, and now the platform on which Nordic Rebalance builds international partnerships.
About Vitorgan Arzneimittel GmbH
vitOrgan Arzneimittel GmbH is an independent German family-owned Pharmaceutical company in its third generation, with over 70 years of experience in regenerative biomedicine. As a leading expert in biomolecular cell therapy, vitOrgan combines a globally unique manufacturing process of low-molecular, cytoplasmic cell extracts with decades of clinical experience.
